Kent Imaging Appoints Jeffrey Niezgoda, MD., as Chief Medical Officer, Limb Preservation

Dr. Jeffrey Niezgoda, Marketing Director

An experienced healthcare executive and wound care expert provide proven expertise and guidance on the use of near-infrared imaging technology.

Snapshot technology is truly revolutionary and will have an indelible impact on the practice of wound care.

— Dr. Jeffrey Niezgoda

CALGARY, AB, CANADA, March 17, 2022 /EINPresswire.com/ — Kent Imaging is pleased to announce the appointment of Jeffrey Niezgoda, MD, FACHM, MAPWCA, CHWS as Chief Medical Officer. In his new role, Dr. Niezgoda will be responsible for providing medical and clinical leadership for Kent’s wound care, hyperbaric and vascular surgery product strategy and clinical integration.

Dr. Niezgoda is dedicated to excellence in clinical wound, vascular, and regenerative services as Founder and Chairman Emeritus of AZH Wound & Hyperbaric Medicine. He is President and Chief Marketing Officer of WebCME, an international education company providing wound care and hyperbaric education. He is president of the American Professional Wound Care Association and past president of the American College of Hyperbaric Medicine. As an early adopter and supporter of Kent’s flagship SnapshotNIR product, Dr. Niezgoda has been using the device for nearly 4 years.

“I am honored to be Kent Imaging’s Chief Medical Officer. The Snapshot technology is truly revolutionary and will have an indelible impact on the practice of wound care,” says Dr. Niezgoda. He adds, “For years, clinicians have relied on crude physical exams and testing devices that, at best, only provided a rough estimate of tissue perfusion. Near-infrared spectroscopy imaging now enables immediate and direct visualization of tissue oxygenation, which truly improves medical decision-making and will provide better patient outcomes. The Kent team is made up of talented and dedicated people who work together to achieve excellence. I’m thrilled to be part of this great organization.”

“Dr. Niezgoda has a strong passion for bringing technology from the research bench to the clinical bedside where it can make a real contribution to reducing complications and improving patient outcomes,” said Pierre Lemire, CEO of Kent Imaging “We are delighted to have him join the Kent team to help optimize the use of SnapshotNIR at all points of care.”

About Kent Imaging, Inc.
Kent Imaging, located in Calgary, Alberta, Canada, is a leading near-infrared tissue oxygenation imaging innovator that develops, manufactures and markets medical technology that supports the management of real-time decision making in wound care, vascular and surgical subspecialties. Kent holds several patents in oxygen imaging technology and continues to provide innovative and advanced diagnostic imaging solutions to help healthcare systems nationally and internationally. For more information about Kent Imaging, visit www.kenimaging.com

Lea Pavlick
Kent Imaging
+1 4035427314
write to us here
Visit us on social media:
Facebook
Twitter
LinkedIn